13.30 -  14.45

POSTGRADUATE COURSE

Complications associated with the use of biomaterials in dialysis

PART I

Patrick SAUDAN, Geneva, (SUI)
Complications of venous catheters
Pierre-Yves MARTIN, Geneva (SUI)
Complications of dialysis membranes

POSTGRADUATE COURSE

European Granting & Technology Transfer

PART I

HEALTH in FP7: Opportunities, participation rules, keys for success

14.45 -  15.15

COFFEE BREAK

15.15 -  16.45

PART II

Menno PRUIJM, Lausanne, (SUI)
Complications of plasmapheresis
Daniel TETA. Lausanne, (SUI)
Complications of peritoneal dialysis

PART II

From the Innovation to the Product

Alexandra RICHARDSON, (UNITEC) Geneva, (SUI)
Intellectual Property and Technology Transfer
Benoit DUBUIS, (President Bioalps Association), Geneva, (SUI)
Regional networks and innovation supports
Jesus MARTIN-GARCIA, Benoit DUBUIS, (ECLOSION) Geneva, (SUI)
From the innovation to the product
(with film – 4 minutes)
Partly supported by BioAlps

17.00 -  18.00

OPENING CEREMONY

Welcome Address

Beat H. WALPOTH, Geneva, (SUI)
ESAO & Congress President

Allocutions

Pierre-François UNGER
State Councillor, economic and health department, Geneva (SUI)
Jean-Dominique VASSALLI
Rector, University of Geneva (SUI)
Patrick FRANCIOLI
Dean, Faculty of Biology & Medicine, University of Lausanne (SUI)

MUSIC

18.00 -  19.00

PLENARY SESSIONS

Jeffrey HUBBELL, EPFL, Lausanne, (SUI)
Molecular and cellular engineering toward artificial organs research
Yan BARRANDON, Joint Chair EPFL - CHUV, Lausanne, (SUI)
Stem cells: teaching old dogs new tricks
Afksendiyos KALANGOS, HUG, Geneva, (SUI)
Clinical application of cardiovascular biomaterials – from the polymer to the patient

MUSIC

19.00 -  20.00

WELCOME RECEPTION

08.30 -  09.30

PLENARY SESSION

LIVER

Igor SAUER, Berlin (GER)
Extracorporeal Liver Support - back from bed to bench
Philippe MOREL, Geneva, (SUI)
Liver transplant:what does the future hold?
Vladimir MIRONOV, Charlston (USA)
Organ Printing: Directed Tissue Self-Assembly

09.30 -  10.00

COFFEE BREAK

10.00 -  11.00

AFFILIATED SOCIETY SYMPOSIUM

ESOT

Organ Viability & Preservation for Transplantation

Henri LEUVENINK, Groningen (NLD)
PreservatIon & Innovative techniques of Perfusion to maintain Organ Viability
Michiel ERASMUS, Groningen (NLD)
Lung Perfusion, Non-Heartbeating Donation and Transplantation
Thierry BERNEY, Geneva, (SUI)
Islet Transplantation

AFFILIATED SOCIETY SYMPOSIUM

ASAIO

Highlights from the
ASAIO 2008 meeting

Michael LYSAGHT, Boston (USA)
Bioengineering
Steve ASH, Lafayette (USA)
Renal
Keefe MANNING, University Park (USA)
Cardiovascular

AFFILIATED SOCIETY SYMPOSIUM

TERMIS

Strategies for Tissue Engineering of Connective Tissues

Rui L. REIS, Porto (POR)
New Strategies for tissue engineering of bone and osteochondral defects
Ivan MARTIN, Basel, (SUI)
Mesenchymal stem cell expansion in 3D perfusion systems

11.00 -  12.00

CORPORATE MEMBERS SYMPOSIUM

Therapy development to meet future patient requirements

Sudhir BOWRY, Bad Homburg (GER)
Fresenius Medical Care,
Uremic toxins – what should and can be removed with current membranes and treatment modalities to improve patient outcomes?
Peter RUTHERFORD, Zürich, (SUI) Baxter, Healthcare,
Simplicity and complexity – treating tomorrows patients
Ingrid LEDEBO, Lund, (SWE)
Gambro
Future development of dialysis

12.00 -  13.30

SUPPORTED LUNCH SYMPOSIUM

Immunosuppression for Transplantation: Update 2008

SUPPORTED LUNCH SYMPOSIUM

Pulsatile versus Non Pulsatile Flow for Cardiac Support

Heinich SCHIMA, Vienna (AUT)
Physiological Aspects of Continuous Flow
Andreas ARNDT, Berlin (GER)
Enhancing the Pulsatility of Rotary Blood Pumps – Options and Limitations
Johannes MÜLLER, Berlin (GER)
Clinical Experience with Semi Pulsatile Blood Flow
Supported by Berlin Heart

SUPPORTED LUNCH SYMPOSIUM

Extracorporeal Blood Circuits for Liver Failure Therapies

Igor SAUER, Berlin (GER)
Clinical Experiences with Extracorporeal Liver Assist Devices
Horst CHRISTMANN, Bad Homburg, (GER)
Technical advances to improve the performance of the Prometheus System
Peter KRISPER, Graz, (AUT)
Optimizing anticoagulation in extra-corporeal blood circuits for liver failure therapy
Supported by Fresenius Medical Care

13.30 -  15.00

ORAL SESSION

Technology in Tissue Engineering

O1 BIOPRINTING OF BLOOD VESSELS: VASCULAR TISSUE SPHEROIDS AS BUILDING BLOCKS
Carmine Gentile et al, Charleston, Sc, (USA)

O2 BIOLOGICAL SKIN REPLACEMENT: THE NEED FOR STERILIZATION
Willem F. Wolkers et al, Hannover, (GER)

O3 CRYOPRESERVATION OF TISSUE AND TISSUE ENGINEERED PRODUCTS
Birgit Glasmacher et al, Hannover, (GER)

O4 MECHANOTRANSDUCTION-BIOREACTOR FOR TISSUE ENGINEERING OF A URETER PROSTHESIS
Christoph Becker et al, Aachen, (GER)

O5 TISSUE ENGINEERING ARTERY UTILIZING THE PHYSIOLOGIC PULSATILE BIOREACTOR
Kiyotaka Iwasaki et al, Tokyo, (JPN)

O6 DEVELOPMENT OF A PRODUCTION PROCESS FOR STEM CELL BASED CELL THERAPEUTIC IMPLANTS
Peter M. Czermak et al, Giessen, (GER)

ORAL SESSION

Cardiovascular Implants I: Valves and Myocardium

O7 THE EFFECTS OF FLUID PROPERTIES AND FLOW CONDITIONS ON LOCAL BI-LEAFLET MECHANICAL HEART VALVE HEMODYNAMICS
Keefe B. Manning et al, University Park, (USA)

O8 TITANIZED GLUTARALDEHYDE FIXED HEART VALVE PROSTHESES WITH LESS CALCIFICATION AND TOTAL ENDOTHELIALIZATION
Norbert W. Guldner et al, Lübeck, (GER)

O9 ASSESSMENT OF BIO-MECHANICAL PERFORMANCE OF THE NEW BIOPROSTHESIS (KALANGOS® HEART VALVE) IN THE SHEEP MODEL
Mustafa Cikirikcioglu et al, Geneva, (SUI)

O10 OFF-PUMP TRANSVENTRICULAR PULMONARY REPLACEMEMT USING A DECELLULARIZED PORINE VALVE ON A SLF-EXPANDABLE STENT : A NEW APPROACH FOR PULMONARY VALVE INCOMPETENCE?
Ivan Bouzguenda et al, Lille, (FRA)

O11 ATRIOVENTRICULAR VALVE REPAIR USING A BIODEGRADABLE ANNULOPLASTY RING IN CHILDREN
Mustafa Cikirikcioglu et al, Geneva, (SUI)

O12 EMBRYONIC STEM CELL-BASED TISSUE ENGINEERING FOR THE REGENERATION OF THE INFARCTED HEART
Marisa E. Jaconi et al, Geneva, (SUI)

ORAL SESSION

One Day on the Liver - Scientific Session

O13 A NEW APPLICATION OF THE AMC-BIOARTIFICIAL LIVER: A MODEL TO STUDY THE ESTABLISHMENT OF METABOLIC ZONATION IN THE LIVER
Ruurdtje Hoekstra et al, Amsterdam, (NED)

O14 A NEW SYSTEM OF SUB-NORMOTERMIC PERFUSION FOR LIVER PRESERVATION IN A PIG MODEL
Enrico Gringeri et al, Padova, (ITA)

O15 TRANSPLANTATION OF IMMORTALIZED HUMAN HEPATOCYTES IMPROVES SURVIVAL WITHOUT INCREASE OF NATIVE LIVER REGENERATION IN ACUTE LIVER FAILURE.
Antonino Sgroi et al, Geneva, (SUI)

O16 BEHAVIOUR OF HUMAN HEPATOCYTE IN AMMONIA PLASMA–GRAFTED PEEK-WC-PU MEMBRANE BIO-HYBRID SYSTEM
Simona Salerno et al, Rende, Cs, (ITA)

O17 LABELLING OF PRIMARY HUMAN HEPATOCYTES WITH MICRON-SIZED IRON OXIDE PARTICLES IN TEMPORARY SUSPENSION CULTURE
Nora N. Kammer et al, Berlin, (GER)

O18 ONLINE HDF SYSTEM WITH GOOD REMOVAL CAPACITY OF GLUTAMINE BRINGS GOOD CLINICAL EFFECT
Kazuaki Inoue et al, Yokohama, (JPN)

SPECIAL SYMPOSIUM

WAA – ESFH I

Dieter FALKENHAGEN, Krems (AUT)
Adsorption of endotoxins: new possibilities using old principles
Jens ALTRICHTER, Rostock (GER)
Extracorporeal cell therapywith granulocytes in sepsis and septic shock – in vivo and clinical results.
Martin SCHOLZ, Düsseldorf (GER)
The leukocyte inhibition module
in apheresis –
immunomodulation in cardiac
surgery, intensive care and
autoimmine disease
Dieter FALKENHAGEN, Krems (AUT)
Citrate anticoagulation in apheresis treatment – how to optimise
Volker WITT, Vienna (AUT)
Anticoagulation with citrate and electrolyte imbalance in children during apheresis

15.00 -  16.00

16.00 -  17.30

ORAL SESSION

Transplantation - Organ Preservation and Marginal Organs

O19 RECOVERY OF WARM ISCHEMICALLY DAMAGED KIDNEYS USING A NOVEL ORGAN PERFUSION SYSTEM
Marie-Claire J.M. Schreinemachers et al, Amsterdam, (NED)

O20 HYPOTHERMIC IN SITU MACHINE PERFUSION OF DONOR ORGANS DURING NON-HEART-BEATING DONATION
Edwin F. Dierselhuis et al, Groningen, (NED)

O21 ORGAN RECOVERY USING EXTRACORPOREAL SUPPORT IMPROVES FUNCTION OF RENAL GRAFTS FROM DONORS AFTER CIRCULATORY DETERMINATION OF DEATH (DCDD)
Alvaro Rojas et al, Ann Arbor, (USA)

O22 OXIDATIVE STRESS IN KIDNEY TRANSPLANT RECIPIENTS
Nicole Lanci et al, Bologna, (ITA)

O23 A NEW MACHINE, MAGNETIC RESONANCE COMPATIBLE, ABLE TO TEST, BY GADOLINIUM PERFUSION IMAGING, THE VASCULAR ANATOMY AND THE QUALITY OF PERFUSION IN MARGINAL KIDNEYS REANIMATED BY OXYGENATED HYPOTHERMIC PULSATILE PERFUSION.Jean-Bernard Buchs et al, Genève, (SUI)

O24 MOLECULAR ADSORBENTS RECIRCULATING SYSTEM (MARS) DIALYSIS FOR GRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATION : SINGLE CENTER EXPERIENCE
Jiyoung Y. Lee et al, Seoul, (KOR)

ORAL SESSION

Cardiovascular Implants II: Grafts and Stents

O25 MECHANOTRANSDUCTION OF ENDOTHELIAL CELLS: UPTAKE OF QUANTUM DOTS UNDER CONTROLLED SHEAR STRESS CONDITIONS
Anette Runtemund et al, Hanover, (GER)

O26 EVALUATION OF THROMBOGENIC POTENTIAL OF ELECTROSPUN BIORESORBABLE VASCULAR GRAFT MATERIALS
Patricia S. Wolfe et al, Richmond, (USA)

O27 FEATURES OF DECELLULARIZED AORTIC MATRICES SEEDED WITH ENDOTHELIAL CELLS IN A NEWLY DEVELOPED PULSATILE FLOW BIOREACTOR
Martina Seifert et al, Berlin, (GER)

O28 VASCULAR TISSUE ENGINEERING USING MESENCHYMAL STEM-CELLS (MSCS) SEEDING ON SYNTHETIC BIODEGRADABLE VASCULAR GRAFTS
Alessio Rungatscher et al, Geneva, (SUI)

O29 DRUG ELUTING DEGRADABLE SYNTHETIC VASCULAR PROSTHESES
F. Innocente et al, Geneva, (SUI)

O30 VIRTUAL STENTING FOR CUSTOMISATION OF ENDOVASCULAR DEVICES
Catrin Bludszuweit-Philipp et al, Rostock, (GER)

ORAL SESSION

Biomaterials

O31 ENDOTHELIALISATION OF ARTIFICIAL POLY 4-METHYL-1-PENTENE (PMP) MEMBRANES WITH GAS EXCHANGE PROPERTIES
Christian Hess et al, Hannover, (GER)

O32 MODIFICATION OF COLLAGEN/PEO NANOFIBER SCAFFOLDS USING METALLIC NANOPARTICLES
Andreas Szentivanyi et al, Hannover, (GER)

O33 HETEROTYPIC INTERACTION OF FIBROBLASTS AND ENDOTHELIAL CELLS ON RESTRICTED AREA
Stefania Lamponi et al, Siena, (ITA)

O34 ADHESION AND DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS ON BIOGENIC POLYELECTROLYTE MULTILAYERS
Thomas M. Groth et al, Halle-Saale, (GER)

O35 CO-CULTIVATION OF DIFFERENT CELL TYPES ON SPIDER SILK FIBRES
Anja R. Hillmer et al, Hannover, (GER)

O36 POROUS BIODEGRADABLE MICROFIBERS FOR SCAFFOLD MANUFACTURING
Giuseppe A. Perale et al, Milan, (ITA)

Young Investigators’ Liver Session

Saba Habibollah, Newcastle (GBR)
Beyond haematology: cord clood for liver therapy

Nils Bilecke, Berlin (GER)
The Multicompartment SlideReactor: a novel concept for continuous monitoring of co-cultured cells
Jean-Mathieu Prot, Compiègne (FRA)
Growth characterisation of hepatocarcinoma cells cultivated in a microfluidic biochip
Simona Salerno, Rende (ITA)
Membrane biohybrid systems for liver tissue engineering
Stephan Harm, Krems (AUT)
Encapsulated Liver Cells for the Hybrid MDS
Partly supported by Fresenius Medical Care

19.00 -  20.00

CONCERT - Partly Sponsored by the Wilmsdorf Foundation

08.30 - 09.30

PLENARY SESSION

HEART

Daniel LOISANCE, Créteil (FRA)
Permanent artificial ventricles: the optimal therapy for end-stage cardiac patients ?
Giuseppe FAGGIAN, Verona (ITA)
Present and Future of heart transplantation
Axel HAVERICH, Hannover (GER)
Ventricular Assist Devices- The Biological Solution

10.00-11.00

AFFILIATED SOCIETY SYMPOSIUM

SWISS TRANSPLANT SOCIETY

Current and Future Options for Transplantation

Michael DICKENMANN, Basel (SUI)
Living donation in kidney transplantation
Markus WEBER, Zurich, (SUI)
Immunosuppression – State-of-the-Art 2008
Leo BUHLER, Geneva, (SUI)
Update on Xenotransplantation
With the kind support of Wyeth Pharmaceuticals

AFFILIATED SOCIETY SYMPOSIUM

JSAO

Highlights from the Japanese Society for Artificial Organs

Tomohiro NISHINAKA, Kenji YAMAZAKI, Tokyo (JPN)
Mechanical circulatory support
Mitsuo UMEZU, Waseda (JPN)
Contribution of biomedical engineering
Keiichi KANDA, Kyoto (JPN)
New approach in tissue engineering
Yasuharu OHGOE and Yasuhiro FUKUI, Tokyo (JPN)
DLC (Diamond Like Carbon) coating technology for artificial organs

AFFILIATED SOCIETY SYMPOSIUM

ESB

Biomaterials for Soft Tissue Engineering

Dirk GRIJPMA, Enschede (NLD)
Flexible and elastic polymeric structures for cardiovascular tissue engineering
James KIRKPATRICK, Mainz (GER)
Biomaterial interactions with human endothelial lineage cells for promoting angiogenesis

11.00-12.00

SPECIAL SYMPOSIUM

WAA – ESFH - II

Loic GUILLEVIN, Paris (FRA)
Apheresis and ANCA associated vascilitis
Bernd STEGMAYR, Umea (SWE)
World Apheresis Association Registry: Benefits and New Approaches
Heinrich PROPHET, Rostock (GER)
World Apheresis Association Registry: Data of LDL-apheresis and concepts of how to enable comparison with a control group
Volker WITT, Vienna (AUT)
World Apheresis Association Registry: Pediatric data.  Are they totally different?

SPECIAL SYMPOSIUM

HEART

From Heart Imaging to Destination

Thomas SCHMITZ-RODE, Aachen (GER)
Implantation of cardiovascular devices: significance and future role of image guidance
Marvin SLEPIAN, Tucson (USA)
The SynCardia Total Artificial Heart: Present and Future Applications in the Management of Advanced Heart Failure
Georg WIESELTHALER, Vienna (AUT)
Anticoagulation during heart support 2008:is there anything new?

SPECIAL SYMPOSIUM

TISSUE ENGINEERING

Scaffold and Cell Assembly?

Gary BOWLIN, Richmond (USA)
Bioresorbable vascular graft design and development
Suwan JAYASINGHE, London (GBR)
Cell scaffolding
Nicolas L'HEUREUX, Novato (USA)
Sheet-Based Tissue Engineering for Vascular Applications

12.00-13.30

SUPPORTED LUNCH SYMPOSIUM

Percutaneous/apical aortic valve replacement

Stephan Windecker, Bern (SUI)
Percutaneous aortic valve replacement using a transfemoral approach

Friedrich ECKSTEIN, Basle (SUI)
Percutanous aortic valve replacement using a transapical approach

Hermann Reichenspurner, Hamburg (GER)
Catheter-based Aortic Valve Replacement using the Repositionable and Retrievable Direct Flow Device

Supported by Edwards / Corevalve / Direct Flow Medical

SUPPORTED LUNCH SYMPOSIUM

Mid and long-term VAD – Today's Gold Standard

Stephen WESTABY, Oxford (GBR) Mid-term support with Levitronix
Giuseppe FAGGIAN, Verona (ITA)
From Post Cardiotomy in Acute Heart Failure to Bridge to Destination
Discussion
Supported by 4Competence / Thoratec / Levitronix

SUPPORTED LUNCH SYMPOSIUM

Lung Support

Khosrow MOTTAGHY, Aachen (GER)
Introduction
S. UHLIG, Aachen (GER)
Mechanisms of ventilator-induced lung injuries
M. QUINTEL, Göttingen (GER)
Extracorporeal long-term support of the lung
S. ROUSSEAU, Berlin (GER)
Extracorporeal breathing pump support to wean patients from mechanical ventilation
Ali KILIC, Berlin (GER)
Use of pulsatile ventricular assist device (Berlin Heart EXCOR®) and an interventional lung assist device (NovaLung®) in an animal model
Y. YAMAMOTO, Kagawa (JPN)
Experimental study of the regeneration pattern of canine tracheal cartilage
Partly supported by Novalung

13.30-15.00

ORAL SESSION

Kidney I - Clinical Outcome

O37 WORLD APHERESIS REGISTRY 2003-2007 DATA.
Bernd G. Stegmayr et al, Umea, (SWE)

O38 SAVING LIVES WITH PERITONEAL DIALYSIS IN POTENTIALLY FATAL ACUTE RENAL FAILURE FOLLOWING CHILDHOOD WASP STING
Prayong Vachvanichsanong et al, Hat Yai, (THA)

O39 ASSESSMENT OF THE RISK FOR CARDIOVASCULAR MORTALITY AND MORBIDITY OF HEMODIALYSIS PATIENTS
Stefan Arsov et al, Groningen, (NLD)

O40 HIGH CUT-OFF HAEMODIALYSIS LOWERS INFLAMMATORY STATUS IN CHRONIC DIALYSIS PATIENTS
Colin A. Hutchison et al, Birmingham, (GBR)
O41 A PILOT RANDOMIZED CONTROLLED TRIAL OF HIGH-VOLUME HEMOFILTRATION IN RHABDOMYOLYSIS
Demetrios J. Kutsogiannis et al, Edmonton, (CAN)

O42 LONG-TERM (≥30 YEARS) RENAL REPLACEMENT THERAPY (RRT) SURVIVORS IN SLOVENIA
Jadranka Buturovic-Ponikvar et al, Ljubljana, (SLO)

ORAL SESSION

Cardiac Assist Devices I

O43 A BLOOD PUMP FLOW VISUALIZATION USING A WALL-PIV TECHNIQUE
André Berthe et al, Berlin, (GER)

O44 THE INFLUENCE OF END-DIASTOLIC TIMING ON THE FLOW WITHIN A PULSATILE PEDIATRIC VENTRICULAR ASSIST DEVICE
Benjamin T. Cooper et al, University Park, (USA)

O45 HYDRODYNAMIC ANALYSIS OF TRANSVENTRICULAR APICAL AORTIC CANNULATION
Ikuo Fukuda et al, Hiorosaki, Aomori, (JPN)

O46 GEOMETRY AND FLOW
OPTIMIZATION OF THE AACHEN TOTAL ARTIFICIAL HEART “ACCOR”
Marco Laumen et al, Aachen, (GER)

O47 HYDRO-DYNAMIC IDENTIFICATION OF AN AXIAL FLOW VENTRICUAR ASSIST DEVICE
Francesco Moscato et al, Rende, (ITA)

O48 INPUT COMPLIANT CHAMBER IMPROVES THE UNLOADING OF THE NATIVE VENTRICLE IN PULSATILE MCSS APPLICATIONS.

ORAL SESSION

Various Medical Implants

O49 LONG-TERM IMPLANTATION OF SUBCUTANEOUSLY IMPLANTABLE ARTIFICIAL SPHINCTERS
Yun Luo et al, Sendai, (JPN)

O50 UROCORTIN IS RELEASED FROM ISCHEMIC, THOUGH VIABLE, CARDIAC CELLS, BEFORE THE OCCURRENCE OF IRREVERSIBLE INJURY. IS A NEW CLINICAL MARKER OF SUBLETHAL CARDIAC ISCHEMIA BE BORN?
Giuseppe Faggian et al, Verona(ITA)

O51 MITOCHONDRIAL RELOCATION OF PKC-E IN UROCORTIN-POSITIVE CARDIAC MYOCYTES OF PATIENTS UNDERGOING ON-PUMP CARDIAC SURGERY
Giuseppe Faggian et al, Verona, (ITA)

O52 POLYETHYLENIMINE DERIVATIVES FOR TARGETED GENE DELIVERY
Deling Kong et al, Tianjiin, (CHN)

O53 NITRIC OXIDE IN RAT MODEL OF ACUTE RESPIRATORY DISTRESS SYNDROME
Gi-Beum Kim et al, Jeonju, (KOR)

O54 STRAIGHT AND FLARED STENT GRAFTS IN VENOUS ANASTOMOSES OF ARTERIOVENOUS ACCESS FOR HEMODIALYSIS

16.00-17.30

ORAL SESSION

Kidney II - Complications and Biologic Effects

O55 EFFECTS OF SEQUENTIAL CONVECTIVE THERAPY (SCT) BASED ON RELATIVE BLOOD VOLUME (BV) CHANGES ON INTRA-DIALYTIC HYPOTHENSION EPISODES. A MULTICENTER TRIAL
Giovanni M. Frasca' et al, Ancona, (ITA)

O56 SOLUTE REMOVAL WHEN MODIFYING ONLY HEMODIALYSIS DURATION
Sunny Eloot et al, Gent, (BEL)

O57 DEVELOPMENT OF RECOMBINANT FOOD GRADE LACTIC ACID BACTERIUM FOR REMOVAL OF UREA IN TREATMENT OF RENAL FAILURE
Deling Kong et al, Tianjiin, (CHN)

O58 REDUCTION OF NT-PROBNP AFTER HEMODIALYSIS.
Bernd G. Stegmayr et al, Umea, (SWE)

O59 THE MAGNITUDE OF SERUM ANTIOXIDANT CAPACITY IMPAIRMENT DURING HEMODIALYSIS
Robert A. Stolarek et al, Lodz, (POL)

O60 BACTERIAL ERADICATION IN EXISTING MICROBIAL BIOFILMS BY ZURAGEN™ (METHYLENE BLUE, CITRATE, ANTISEPTIC SOLUTION)
Stephen R. Ash et al, Lafayette, (USA)

ORAL SESSION

Cardiac Assist Devices II and Lung Support

O61 FUNCTIONAL EXAMINATION OF AN ARTIFICIAL MYOCARDIUM WITH SHAPE MEMORY ALLOY FIBRE IN CHRONIC ANIMAL EXPERIMENT
Yasuyuki Shiraishi et al, Sendai, (JPN)

O62 INITIAL RESULTS OF THE CLINICAL TRIAL WITH A NEW LVAD PROVIDING SYNCHRONOUS PULSATILE FLOW
Carlo Pellegrin et al, Pavia, (ITA)

O63 PREDICTABILITY OF OUTCOME AFTER WEANING FROM LEFT VENTRICULAR ASSIST DEVICES IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY
Michael Dandel et al, Berlin, (GER)

O64 INTERMACS-CLASSIFICATION IS UNABLE TO PREDICT SURVIVAL IN BRIDGING TO TRANSPLANTATION; LESS INVASIVE VAD-THERAPY MAY IMPROVE SURVIVAL
Jef Geens et al, Leuven, (BEL)
O65 MEAN RETENTION TIME (MRT): A NEW INDICATOR OPTIMIZING OXYGENATOR’S DESIGN
Hadi Tabesh et al, Aachen, (GER)

O66 CELLULAR ACCUMULATIONS ON POLY-METHYLPENTEN MEMBRANES DECREASED EFFICIENCY OF EXTRACORPOREAL MEMBRANE OXYGENATION
Karla Lehle et al, Regensburg, (GER)

ORAL SESSION

Bioartificial Tissue: Musculo Skeletal

O67 EXPRESSION OF MATRIX METALLOPROTEINASES AND XENOBIOTIC METABOLISM-RELATED ENZYMES IN A FULL-THICKNESS SKIN EQUIVALENT
Karsten R. Mewes et al, Düsseldorf, (GER)

O68 BMP-7 LOADED MICROSPHERES AS A NEW DELIVERY SYSTEM FOR THE CULTIVATION OF HUMAN CHONDROCYTES IN A COLLAGEN TYPE-I GEL: THE COMMON NUDE MOUSE MODEL.
Karsten Gavenis et al, Aachen, (GER)

O69 HEMATOPOIETIC STEM CELLS IN ACUTE SPINAL CORD INJURY. EXPERIMENTAL IN WISTAR RATS..
Katherine A.T. Carvalho et al, Curitiba, (BRA)

O70 INTERVERTEBRAL DISC AUGMENTATION - AN ALTERNATIVE
E. Bono et al, Wädenswil, (SUI)

O71 POLYHYDROXYBUTIRATE (PHB) FROM SUGAR CANE AS BIOMATERIAL FOR BONE TISSUE ENGINEERING USING MESENCHYMAL STEM CELLS DERIVED FROM HUMAN DENTAL PULP.
Vinicius Marchiori-Silva et al, São Paulo, (BRA)

O72 DEVELOPMENT OF A CELL ENCAPSULATION APPROACH FOR HUMAN ANTI-TUMOR IMMUNOTHERAPY
Nicolas Mach et al, Geneva, (SUI)

17.30-18.00

ESAO GENERAL ASSEMBLY

19.00

CONGRESS DINNER

08.30-09.30

PLENARY SESSION

KIDNEY

Raymond VANHOLDER, Ghent (BEL)
Best Supportive Therapy for End-stage Renal Disease
Rutger PLOEG, Groningen (NLD)
Results in Kidney Transplantation in 2008:Opportunities and Limitations
Mike LYSAGHT, Boston (USA)/
Edward LEONARD, New York (USA)
New Directions for treating ESRD: back to the future

09.30-11.00

Working Group Session

EUTOX

Griet GLORIEUX, Ghent (BEL)
New insights in the toxicity of protein bound molecules
Ziad MASSY, Amiens (FRA)
Vascular calcification and CVD in CKD
Joachim JANKOWSKI, Berlin (GER)
Metabolomic research and CKD

ORAL SESSION

Angiogenesis in Cardiovascular Implants

O73 BIOTUBES DESIGNED FOR LARGE ANIMALS : AUTO-IMPLANTATION TO THE CAROTID ARTERY OF THE BEAGLE DOGS
Taiji Watanabe et al, Kyoto, (JPN)

O74 CUSTOM DESIGN OF MICROENVIRONMENT FOR CARDIAC TISSUE ENGINEERING
Claudia M. Haller et al, Bern, (SUI)

O75 SUCCESSFUL ENDOLUMINAL IMPLANTAION OF SMALL DIAMETER AUTOLOGOUS TISSUE-COVERED STENTS “BIOCOVERED STENTS” TO THE ANIMALS: RAPID TISSUE REGENERATION IN VIVO.
Keiichi Kanda et al, Kyoto, (JPN)

O76 MECHANICAL PROPERTIES AND IN VIVO EVALUATION OF ELECTROSPUN SMALL CALIBER VASCULAR GRAFTS
Christian Grasl et al, Vienna, (AUT)

O77 MYOCARDIAL ASSISTANCE BY GRAFTING A NEW UPGRADED BIOARTIFICIAL MYOCARDIUM (MAGNUM TRIAL): CLINICAL RESULTS AT 2 YEARS

Juan C. Chachques et al, Paris, (FRA)

O78 Intramyocardial bone marrow stem cell therapy in CABG surgery for chronic ischemia
Gustav Steinhoff, Rostock, (GER)
INVITED SPEAKER

ORAL SESSION

Computer Modelling

O79 MINIATURE-SIZED SENSOR FOR MEASURING PRESSURE DISTRIBUTION IN ARTIFICIAL ORGANS
Masaki Akiyama et al, Tokyo, (JPN)

O80 MICROFLUIDIC ANALYSIS OF ERYTHROCYTE DEFORMATION FOR STUDYING FLOW-INDUCED HEMOLYSIS
Takanobu Yagi et al, Tokyo, (JPN)

O81 ADEQUACY INDICES FOR DIALYSIS IN ACUTE RENAL FAILURE: KINETIC MODELING
Malgorzata Debowska et al, Warsaw, (POL)

O82 VISUALIZATION OF BASIC FLOW PATTERN IN A SUBARACHNOID HEMORRHAGE MODEL WITH PIV-MEASUREMENT SYSTEM
Dieter Liepsch et al, München, (GER)

O83 NUMERICAL PREDICTION OF THROMBUS FORMATION AND GROWTH IN MEDICAL DEVICES

Catrin Bludszuweit-Philipp et al, Rostock, (GER)

O84 TRANSIENT FLOW FIELD SIMULATION THROUGH A MECHANICAL TRILEAFLET HEART VALVE PROSTHESIS
Torsten Linde et al, Aachen, (GER)

Working Group Session

HEART

1. Options for shear stress reduction in rotary blood pumps.  J. Mueller, K. Graichen, J. Mueller, P. Nuesser.

2. The Completely Implantable DLR-VAD: In Vivo and an Vitro Results. B. Vodermayer, T. Schmid., W. Schiller, A. Welz, D. Liepsch, G. Hirzinger.

3. BestBeat VAD:  preliminary results of the ongoing Clinical Study as bridge to transplant and plans for upcoming Study on heart recovery. S. Rinaldi, S. Sauri.

4. Ongoing Projects in Vienna.
E. Shima, H. Bergmeister, G. Wieselthaler.

5. Method to investigate the flow in the vicinity of the wall in bloodpumps.
U. Kertzscher

6. Plate-plate shearing device to shear and simultaneously observe platelets.
K. Affeld

7. Ongoing Projects at the HIA: An Update.
U. Steinseifer

8. Current projects in Leuven.
B. Meyns

9. Mechanical Circulatory Support in a Spanish Hospital.
A. Pinto, M. Ruiz, J. Roda, R. Perez-Caballero

10. Update on the Adult and Pediatric Support Programme at the University of Geneva.
M. Cikirikcioglu, E. Pektok, J. Sierra, D. Vala, B.H. Walpoth,A. Kalangos.

11. Experimental and clinical data on pulsatile versus non-pulsatile Cardio Pulmonary. Bypass.
G. Rakhorst

12. The state of the art of clinical utilization of the Polish Pneumatic Cardiac Assist System POLCAS and future prospects.
R. Kustosz

13. First validation of the new hybrid circulatory model prototype: testing of parallel ventricular assistance (joint cooperative Italian-Polish project).
K. Zielinski , M. Kozarski, G. Ferrari, K. Gorczynska, K. J. Palko, D. Bozewicz, M. Darowski.

14. Third Generation Assist Devices. 
M. Morshuis

11.00-11.30

COFFEE BREAK

11.30-13.00

ORAL SESSION

Kidney III - Coagulation and Vascular Access

085 ACCESS BLOOD FLOW & DIALYSIS EFICIENCY
Beat von Albertini, Lausanne (SUI)
INVITED SPEAKER

O86 HEMODIAFILTRATION AND HEMOLYSIS
Luca E. Bernardi et al, Como, (ITA)

O87 IN VITRO CITRATE CLEARANCE IN DIALYSIS
Jens Hartmann et al, Krems, (AUT)

O88 SELF-CENTERING CENTRAL VENOUS CATHETER FOR DIALYSIS (CENTROS™), INITIAL CLINICAL RESULTS
Stephen R. Ash et al, Lafayette, (USA)

O89 A DUAL LUMEN VENOUS CATHETER FOR OPTIMISED HAEMOFILTRATION USE
Saad Abdel-Sayed et al, Lausanne, (SUI)

O90 COMPLICATIONS ASSOCIATED WITH TUNNELED CUFFED DIALYSIS CATHETERS

ORAL SESSION

Stem Cells in Bioengineering

O91 ENABLING BIO-TECHNOLOGIES FOR A GLANDULAR STEM CELL-CARDIO- MYOPEXY
Norbert W. Guldner et al, Lübeck, (GER)

O92 PULMONARY TISSUE ENGINEERING USING DUAL-COMPARTMENT POLYMER CONSTRUCTS WITH INTEGRATED VASCULAR TREE
Clemens Fritsche et al, Berlin, (GER)

O93 COLLAGEN AND FIBRONECTIN SUBSTRATES MEDIATED LOCAL SDF-1 GENE EXPRESSION INDUCES STEM CELLS HOMING
Nan Ma et al, Rostock, (GER)

O94 IMAGING OF HUMAN MYOBLAST TRANSPLANT BY BIOLUMINESCENCE USING RENILLA-LUCIFERASE TRANSGENE EXPRESSION
Thomas Laumonier et al, Genève, (SUI)

O95 ARE CORD BLOOD CELLS BETTER THAN BONE MARROW CELLS FOR MYOCARDIAL CELL THERAPY AND TISSUE ENGINEERING?
Christof Stamm et al, Berlin, (GER)

O96 NUCLEAR REPROGRAMMING OF ADIPOCYTES BY THE HIGH MOBILITY GROUP PROTEIN HMGA2
Jörn Bullerdiek et al, Hannover, (GER)

ORAL SESSION

Computer Modelling and Robotics

O97 ENDOTHELIAL NO RELEASE AND VASODILATATION UNDER CONTINUOUS OR PULSATILE CPB: MODELLISTIC STUDY AND CLINICAL INVESTIGATION
Giuseppe Faggian et al, Verona, (ITA)

O98 HYDRODYNAMICS OF ARTERIAL PERFUSION IN EXTRACORPOREAL CIRCULATION: FROM REALITY TO VIRTUAL SIMULATION
Ikuo Fukuda et al, Hiorosaki, Aomori, (JPN)

O99 IN VITRO DYNAMIC PIV FLOW FIELD ANALYSES OF THE MECHANICAL BI-LEAFLET VALVES: INFLUENCE OF PULSE WAVEFORM AND WORKING FLUID VISCOSITY

O100 BEHAVIOUR MODIFICATION AND ELECTRIC GASTRIC STIMULATION
Bashir A. Zikria et al, New York, (USA)

O101 IMPROVING MOTOR RELEARNING EFFICACY BY APPLYING FUNCTIONAL MOVEMENTS WITH A THERAPY ROBOT
Stefan Mina et al, Wr. Neustadt, (AUT)

13.00-13.30

CLOSING CEREMONY

B. MEYNS

Incoming President 2008-2010

ESAO - WICHTIG AWARD 2008

Awardee Presentation

C. LEGALLAIS

Congress Organiser 2009

B. H.WALPOTH

Outgoing President 2006-2008